The road to biological pacing

Nature Reviews Cardiology

Volumn 8, Issue 11, 2011, Pages 656-666

  Rosen, Michael R ^a   Robinson, Richard B ^a   Brink, Peter R ^a   Cohen, Ira S ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; CALCIUM ION; CALMODULIN; CASPASE 3; CD3 ANTIGEN; CONNEXIN 43; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HERMES ANTIGEN; IMMUNOGLOBULIN G; PHOSPHODIESTERASE; POTASSIUM CHANNEL; SODIUM CHANNEL; SODIUM ION;

BIOLOGICAL PACING; ELECTROSTIMULATION; GENE CONTROL; GENE OVEREXPRESSION; GENE TARGETING; HEART PACING; HEART RATE; HUMAN; MECHANICAL STIMULATION; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SINUS RHYTHM;

ARRHYTHMIAS, CARDIAC; BIOMEDICAL TECHNOLOGY; CARDIAC PACING, ARTIFICIAL; HUMANS;

EID: 80055025823     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2011.120     Document Type: Review

References (75)

1. Hoffman, B.F. & Cranefield, P.F. Electrophysiology of the Heart (Futura Publishing, Armonk, 1960).
2. Jalife, J., Delmar, M., Davidenko, J.M. & Anumonwo, J.M. Basic Cardiac Electrophysiology for the Clinician (Futura Publishing, Armonk, 1999).
3. Tsien, R.W. & Carpenter, D.O. Ionic mechanisms of pacemaker activity in cardiac Purkinje fibers. Fed. Proc. 37, 2127-2131 (1978).
4. Biel, M., Schneider, A. & Wahl, C. Cardiac HCN channels structure, function, and modulation. Trends Cardiovasc. Med. 12, 206-212 (2002).
5. Bogdanov, K.Y. et al. Membrane potential fluctuations resulting from submembrane Ca2+ releases in rabbit sinoatrial nodal cells impart an exponential phase to the late diastolic depolarization that controls their chronotropic state. Circ. Res. 99, 979-987 (2006). (Pubitemid 44657801)
6. DiFrancesco, D. A study of the ionic nature of the pacemaker current in calf Purkinje fibres. J. Physiol. 314, 377-393 (1981).
7. f) to generation of spontaneous activity in rabbit sino-atrial node myocytes. J. Physiol. 434, 23-40 (1991).
8. Lakatta, E.G., Maltsev, V.A. & Vinogradova, T.M. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ. Res. 106, 659-673 (2010).
9. Lakatta, E.G. & DiFrancesco, D. What keeps us ticking: a funny current, a calcium clock, or both? J. Mol. Cell. Cardiol. 47, 157-170 (2009).
10. Joung, B. et al. Intracellular calcium dynamics and acceleration of sinus rhythm by beta-adrenergic stimulation. Circulation 119, 788-796 (2009).
11. Robinson, R.B. & Siegelbaum, S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu. Rev. Physiol. 65, 453-480 (2003). (Pubitemid 38249163)
12. Chandler, N.J. et al. Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker. Circulation 119, 1562-1575 (2009).
13. Scherf, D. & Schott, A. Extrasystoles and Allied Arrhythmias 2nd edn (Year Book Medical Publishers, Chicago, 1973).
14. Osler, W. Stokes-Adams disease. Ann. Noninvasive Electrocardiol. 7, 79-81 (2002).
15. Adams, R. Cases of diseases of the heart accompanied with pathological observations. Dublin Hospital Reports 4, 353-453 (1827).
16. Stokes, W. Observations on some cases of permanently slow pulse. Dublin Quarterly Journal of Medical Science 2, 73-85 (1846).
17. Zoll, P.M. Resuscitation of the heart in ventricular standstill by external electric stimulation. N. Engl. J. Med. 247, 768-771 (1952).
18. Furman, S. & Schwedel, J.B. An intracardiac pacemaker for Stokes-Adams seizures. N. Engl. J. Med. 261, 943-947 (1959).
19. Zivin, A., Mehra, R. & Bardy, G.H. in Foundations of Cardiac Arrhythmias: Basic Concepts and Clinical Approaches (Eds Spooner, P.M. & Rosen, M.R.) 571-598 (Marcel Dekker Inc., New York, 2001).
20. Rosen, M.R., Brink, P.R., Cohen, I.S. & Robinson, R.B. Cardiac pacing: from biological to electronic to biological? Circ. Arrhythmia Electrophysiol. 1, 54-61 (2008).
21. Kolata, G. In Fixing Faulty Medical Devices, the Cure Can Be Worse Than the Disease. New York Times (6 April 1998).
22. Binggeli, C. et al. Autonomic nervous system-controlled cardiac pacing: a comparison between intracardiac impedance signal and muscle sympathetic nerve activity. Pacing Clin. Electrophysiol. 23, 1632-1637 (2000).
23. Lee, K.L. In the wireless era: leadless pacing. Expert Rev. Cardiovasc. Ther. 8, 171-174 (2010).
24. Rosen, M.R., Brink, P.R., Cohen, I.S. & Robinson, R.B. Genes, stem cells and biological pacemakers. Cardiovasc. Res. 64, 12-23 (2004). (Pubitemid 39208919)
25. Siu, C.W., Lieu, D.K. & Li, R.A. HCN-encoded pacemaker channels: from physiology and biophysics to bioengineering. J. Membr. Biol. 214, 115-122 (2006). (Pubitemid 47063504)
26. Marbán, E. & Cho, H.C. Biological pacemakers as a therapy for cardiac arrhythmias. Curr. Opin. Cardiol. 23, 46-54 (2008). (Pubitemid 351339795)
27. Cingolani, E. et al. Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block [poster PO01-25]. Heart Rhythm 8, S112 (2011).
28. Bucchi, A. et al. Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker. Circulation 114, 992-999 (2006). (Pubitemid 44358875)
29. Zhang, H., Holden, A.V. & Boyett, M.R. Gradient model versus mosaic model of the sinoatrial node. Circulation 103, 584-588 (2001). (Pubitemid 32116245)
30. Cohen, I.S. & Robinson, R.B. Pacemaker current and automatic rhythms: toward a molecular understanding. Handb. Exp. Pharmacol. 171, 41-71 (2006).
31. Qu, J. et al. HCN2 overexpression in newborn and adult ventricular myocytes: distinct effects on gating and excitability. Circ. Res. 89, E8-E14 (2001).
32. Jansen, J.A., van Veen, T.A., de Bakker, J.M. & van Rijen, H.V. Cardiac connexins and impulse propagation. J. Mol. Cell Cardiol. 48, 76-82 (2010).
33. Valiunas, V. et al. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. 555, 617-626 (2004). (Pubitemid 38404584)
34. Valiunas, V. et al. Coupling an HCN2-expressing cell to a myocyte creates a two-cell pacing unit. J. Physiol. 587, 5211-5226 (2009).
35. Plotnikov, A.N. et al. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation 116, 706-713 (2007). (Pubitemid 47255987)
36. Zhang, H. et al. Implantation of sinoatrial node cells into canine right ventricle:biological pacing appears limited by the substrate. Cell Transplant. doi:10.3727/096368911X565038.
37. Rylant, M. Contribution a l'etude de l'automatisme et de la conduction dans le Coeur. Bull. Acad. Med. Belgique 7, 161-200 (1927).
38. Starzl, T.E., Hermann, G., Axtell, H.K., Marchioro, T.L. & Waddell, W.R. Failure of sino-atrial nodal transplantation for the treatment of experimental complete heart block in dogs. J. Thorac. Cardiovasc. Surg. 46, 201-205 (1963).
39. Ernst, R.W. Pedicle grafting of the sino-auricular node to the right ventricle for the treatment of complete atrioventricular block. J. Thorac. Surg. 44, 681-698 (1962).
40. Morishita, Y., Poirier, R.A. & Rohner, R.F. Sinoatrial node transplantation in the dog. Vasc. Endovasc. Surg. 15, 388-393 (1981).
41. Edelberg, J.M., Aird, W.C. & Rosenberg, R.D. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J. Clin. Invest. 101, 337-343 (1998). (Pubitemid 28067330)
42. Edelberg, J.M., Huang, D.T., Josephson, M.E. & Rosenberg, R.D. Molecular enhancement of porcine cardiac chronotropy. Heart 86, 559-562 (2001). (Pubitemid 32999871)
43. Ruhpawar, A. et al. Transplanted fet al cardiomyocytes as cardiac pacemaker. Eur. J. Cardiothorac. Surg. 21, 853-857 (2002).
44. Ruhparwar, A. et al. Adenylate-cyclase VI transforms ventricular cardiomyocytes into biological pacemaker cells. Tissue Eng. Part A 16, 1867-1872 (2010).
45. Mattick, P. et al. Ca2+-stimulated adenylyl cyclase isoform AC1 is preferentially expressed in guinea-pig sino-atrial node cells and modulates the I(f) pacemaker current. J. Physiol. 582, 1195-1203 (2007). (Pubitemid 47104348)
46. Younes, A. et al. Ca2+-stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells. J. Biol. Chem. 283, 14461-14468 (2008).
47. Kryukova, Y. & Robinson, R.B. A key role of Ca2+-activated adenylyl cyclase I in Ca2+-dependence of β-adrenergic modulation of pacemaker current [abstract 2330]. Circulation 120, S625 (2009).
48. Boink, G.J. et al. Introducing the Ca2+-stimulated adenylyl cyclase AC1 into HCN2-based biological pacemakers enhances their function [abstractA16415]. Circulation 122, A16415 (2010).
49. Miake, J., Marbán, E., Nuss, H.B. Biological pacemaker created by gene transfer. Nature 419, 132-133 (2002). (Pubitemid 35025436)
50. Miake, J., Marbán, E. & Nuss, H.B. Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative-suppression. J. Clin. Invest. 111, 1529-1536 (2003). (Pubitemid 38063285)
51. Qu, J. et al. Expression and function of a biological pacemaker in canine heart. Circulation 107, 1106-1109 (2003). (Pubitemid 36297200)
52. Plotnikov, A.N. et al. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 109, 506-512 (2004). (Pubitemid 38168514)
53. Tse, H.F. et al. Bioartificial sinus node constructed via invivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation 114, 1000-1011 (2006).
54. Plotnikov, A.N. et al. HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade. Heart Rhythm 5, 282-288 (2008).
55. Potapova, I. et al. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. 94, 952-959 (2004). (Pubitemid 38490073)
56. Lau, D.H. et al. Epicardial border zone overexpression of skelet al muscle sodium channel, SkM1, normalizes activation, preserves conduction and suppresses ventricular arrhythmia: an insilico, invivo, invitro study. Circulation 119, 19-27 (2009).
57. Protas, L. et al. Expression of skelet al but not cardiac Na+ channel isoform preserves normal conduction in a depolarized cardiac syncytium. Cardiovasc. Res. 81, 528-535 (2009).
58. Coronel, R. et al. Cardiac expression of skelet al muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarction. Heart Rhythm 7, 1104-1110 (2010).
59. Boink, G.J. et al. HCN2/SkM1 gene transfer into the canine left bundle branch induces highly stable biological pacing at physiological beating rates [abstract AB24-2]. Heart Rhythm 8, S54 (2011).
60. Kashiwakura, Y., Cho, H.C., Barth, A.S., Azene, E. & Marbán, E. Gene transfer of a synthetic pacemaker channel into the heart: a novel strategy for biological pacing. Circulation 114, 1682-1686 (2006). (Pubitemid 44607115)
61. Kehat, I. et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 22, 1282-1289 (2004). (Pubitemid 39341201)
62. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-e41 (2009).
63. Novak, A. et al. Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus. Cell Reprogram. 12, 665-678 (2010).
64. Efe, J.E. et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215-222 (2011).
65. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
66. Leda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
67. Mummery, C. Induced pluripotent stem cells-a cautionary note. N. Engl. J. Med. 364, 2160-2162 (2011).
68. Pera, M.F. Stem cells: the dark side of induced pluripotency. Nature 471, 46-47 (2011).
69. Shlapakova, I.N. et al. Biological pacemakers in canines exhibit positive chronotropic response to emotional arousal. Heart Rhythm 7, 1835-1840 (2010).
70. Cho, H.C., Kashiwakura, Y. & Marbán, E. Creation of a biological pacemaker by cell fusion. Circ. Res. 100, 1112-1115 (2007). (Pubitemid 46684124)
71. Rezai, N. et al. Methods for examining stem cells in post-ischemic and transplanted hearts. Methods Mol. Med. 112, 223-238 (2005).
72. Proulx, M.K. et al. Fibrin microthreads support mesenchymal stem cell growth while maintaining differentiation potential. J. Biomed. Mater. Res. A. 96, 301-312 (2011).
73. Rosen, A.B. et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative invivo three-dimensional fluorescence analysis. Stem Cells 25, 2128-2138 (2007). (Pubitemid 47258192)
74. Kraitchman, D.L. & Wu, J.C. (Eds) Stem Cell Labeling for Delivery and Tracking Using Non-Invasive Imaging. (CRC Press, New York, 2011).
75. Climbing Mount Everest is work for supermen. New York Times (18 March 1923).